BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Calarota SA, Aberle JH, Puchhammer-Stöckl E, Baldanti F. Approaches for monitoring of non virus-specific and virus-specific T-cell response in solid organ transplantation and their clinical applications. J Clin Virol. 2015;70:109-119. [PMID: 26305832 DOI: 10.1016/j.jcv.2015.07.299] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.7] [Reference Citation Analysis]
Number Citing Articles
1 O.millán, Brunet M. Cytokine-based immune monitoring. Clinical Biochemistry 2016;49:338-46. [DOI: 10.1016/j.clinbiochem.2016.01.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
2 Vigil D, Konstantinov NK, Barry M, Harford AM, Servilla KS, Kim YH, Sun Y, Ganta K, Tzamaloukas AH. BK nephropathy in the native kidneys of patients with organ transplants: Clinical spectrum of BK infection. World J Transplant 2016; 6(3): 472-504 [PMID: 27683628 DOI: 10.5500/wjt.v6.i3.472] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
3 Ward BJ, Pillet S, Charland N, Trepanier S, Couillard J, Landry N. The establishment of surrogates and correlates of protection: Useful tools for the licensure of effective influenza vaccines? Hum Vaccin Immunother 2018;14:647-56. [PMID: 29252098 DOI: 10.1080/21645515.2017.1413518] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
4 Navarro D. Expanding role of cytomegalovirus as a human pathogen: Cytomegalovirus and Human Disease. J Med Virol 2016;88:1103-12. [DOI: 10.1002/jmv.24450] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
5 Chiereghin A, Piccirilli G, Belotti T, Prete A, Bertuzzi C, Gibertoni D, Gabrielli L, Turello G, Borgatti EC, Barbato F, Sessa M, Arpinati M, Bonifazi F, Lazzarotto T. Clinical utility of measuring Epstein–Barr virus-specific cell-mediated immunity after HSCT in addition to virological monitoring: results from a prospective study. Med Microbiol Immunol 2019;208:825-34. [DOI: 10.1007/s00430-019-00629-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
6 Paez-Vega A, Cantisan S, Vaquero JM, Vidal E, Luque-Pineda A, Lobo-Acosta MÁ, Pérez AB, Alonso-Moralejo R, Iturbe D, Monforte V, Otero-Gonzalez I, Pastor A, Ussetti P, Torre-Cisneros J. Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial. BMJ Open 2019;9:e030648. [PMID: 31420397 DOI: 10.1136/bmjopen-2019-030648] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
7 Ahlenstiel-Grunow T, Pape L. Virus-specific T cells in pediatric renal transplantation. Pediatr Nephrol 2021;36:789-96. [PMID: 32221706 DOI: 10.1007/s00467-020-04522-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Kim HW, Kwon OC, Han SH, Park MC. Positive conversion of interferon-γ release assay in patients with rheumatic diseases treated with biologics. Rheumatol Int 2020;40:471-9. [PMID: 31919575 DOI: 10.1007/s00296-019-04510-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Franceschini E, De Biasi S, Digaetano M, Bianchini E, Lo Tartaro D, Gibellini L, Menozzi M, Zona S, Tarantino G, Nasi M, Codeluppi M, Guaraldi G, Magistri P, Di Benedetto F, Pinti M, Mussini C, Cossarizza A. Efficient T-Cell Compartment in HIV-Positive Patients Receiving Orthotopic Liver Transplant and Immunosuppressive Therapy. J Infect Dis 2021;223:482-93. [PMID: 32620016 DOI: 10.1093/infdis/jiaa395] [Reference Citation Analysis]
10 Valle-Arroyo J, Aguado R, Páez-Vega A, Pérez AB, González R, Fornés G, Torre-Cisneros J, Cantisán S. Lack of cytomegalovirus (CMV)-specific cell-mediated immune response using QuantiFERON-CMV assay in CMV-seropositive healthy volunteers: fact not artifact. Sci Rep 2020;10:7194. [PMID: 32346028 DOI: 10.1038/s41598-020-64133-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Miller S. Monitoring for Viral Infections in Transplant Patients. Clinical Microbiology Newsletter 2016;38:129-34. [DOI: 10.1016/j.clinmicnews.2016.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
12 Grossi PA, Baldanti F, Andreoni M, Perno CF. CMV infection management in transplant patients in Italy. J Clin Virol 2020;123:104211. [PMID: 31879243 DOI: 10.1016/j.jcv.2019.104211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Chiereghin A, Potena L, Borgese L, Gibertoni D, Squarzoni D, Turello G, Petrisli E, Piccirilli G, Gabrielli L, Grigioni F, Lazzarotto T. Monitoring of Cytomegalovirus (CMV)-Specific Cell-Mediated Immunity in Heart Transplant Recipients: Clinical Utility of the QuantiFERON-CMV Assay for Management of Posttransplant CMV Infection. J Clin Microbiol 2018;56:e01040-17. [PMID: 29305542 DOI: 10.1128/JCM.01040-17] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
14 Bae H, Na DH, Chang JY, Park KH, Min JW, Ko EJ, Lee H, Yang CW, Chung BH, Oh EJ. Usefulness of BK virus-specific interferon-γ enzyme-linked immunospot assay for predicting the outcome of BK virus infection in kidney transplant recipients. Korean J Intern Med 2021;36:164-74. [PMID: 32241081 DOI: 10.3904/kjim.2019.339] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Bono P, Orlandi A, Zoccoli A, Salvatore A, Annaloro C, Tagliaferri E, Lunghi G. Quantiferon CMV assay in allogenic stem cell transplant patients. J Clin Virol 2016;79:10-1. [PMID: 27043969 DOI: 10.1016/j.jcv.2016.03.026] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
16 Fernández-Ruiz M, López-Medrano F, Aguado JM. Predictive tools to determine risk of infection in kidney transplant recipients. Expert Rev Anti Infect Ther 2020;18:423-41. [PMID: 32084326 DOI: 10.1080/14787210.2020.1733976] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]